A Trial to Evaluate the Efficacy and Safety of Methoxyetomidate Hydrochloride for Injection (ET-26) for the Induction of General Anesthesia in Elective Surgery Subjects

Anesthesia Induction Clinical Trial

Official title:
A Multicenter, Randomized, Double-blind, Etomidate-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of ET-26 for Induction of General Anesthesia in Subjects Undergoing Elective Surgery

Status Recruiting

Clinical Trial Summary

This is a multicenter, randomized, double-blind, etomidate-controlled phase III clinical trial. The primary objective is to compare the efficacy and safety between ET-26 and etomidate in the induction of general anesthesia in subjects undergoing elective surgery, so as to provide a reference for the marketing registration of methoetomidate hydrochloride for injection.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Anesthesia Induction

Clinical Trial Details

NCT number	NCT06203431
Study type	Interventional
Source	Ahon Pharmaceutical Co., Ltd.
Contact	WEIYI ZHANG, Medicine Doctor
Phone	18980601837
Email	1370461@qq.com
Status	Recruiting
Phase	Phase 3
Start date	October 11, 2023
Completion date	June 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02920879` - Airway Effects of PEEP During Anesthesia Induction.	N/A
Completed	`NCT05631028` - 95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment	N/A
Completed	`NCT03195504` - High-flow Nasal Oxygenation in Obese Patients During Apnea	N/A
Withdrawn	`NCT01103947` - EcoAnaesthesia Facemask Versus Standard Facemask During Anesthesia Induction	N/A
Recruiting	`NCT06144177` - Induction in the Dark	Phase 4